160 related articles for article (PubMed ID: 3239423)
1. Renal sympathetic nerve activation in relation to reserpine-induced depletion of neuropeptide Y in the kidney of the rat.
Pernow J; Thorén P; Millberg BI; Lundberg JM
Acta Physiol Scand; 1988 Sep; 134(1):53-9. PubMed ID: 3239423
[TBL] [Abstract][Full Text] [Related]
2. Release and vasoconstrictor effects of neuropeptide Y in relation to non-adrenergic sympathetic control of renal blood flow in the pig.
Pernow J; Lundberg JM
Acta Physiol Scand; 1989 Aug; 136(4):507-17. PubMed ID: 2571235
[TBL] [Abstract][Full Text] [Related]
3. Neuropeptide Y and noradrenaline mechanisms in relation to reserpine induced impairment of sympathetic neurotransmission in the cat spleen.
Lundberg JM; Pernow J; Fried G; Anggärd A
Acta Physiol Scand; 1987 Sep; 131(1):1-10. PubMed ID: 2890260
[TBL] [Abstract][Full Text] [Related]
4. Co-release and functional interactions of neuropeptide Y and noradrenaline in peripheral sympathetic vascular control.
Pernow J
Acta Physiol Scand Suppl; 1988; 568():1-56. PubMed ID: 3232527
[TBL] [Abstract][Full Text] [Related]
5. Reserpine-induced depletion of neuropeptide Y from cardiovascular nerves and adrenal gland due to enhanced release.
Lundberg JM; Al-Saffar A; Saria A; Theodorsson-Norheim E
Naunyn Schmiedebergs Arch Pharmacol; 1986 Feb; 332(2):163-8. PubMed ID: 3010140
[TBL] [Abstract][Full Text] [Related]
6. Mechanisms underlying changes in the contents of neuropeptide Y in cardiovascular nerves and adrenal gland induced by sympatholytic drugs.
Lundberg JM; Saria A; Franco-Cereceda A; Theodorsson-Norheim E
Acta Physiol Scand; 1985 Aug; 124(4):603-11. PubMed ID: 3840321
[TBL] [Abstract][Full Text] [Related]
7. Effects of vinblastine on neuropeptide Y levels in the sympathoadrenal system, bone marrow and thrombocytes of the rat.
Hemsén A; Pernow J; Millberg BI; Lundberg JM
Agents Actions; 1991 Nov; 34(3-4):429-38. PubMed ID: 1810152
[TBL] [Abstract][Full Text] [Related]
8. Differential effects of clonidine and reserpine treatment on neuropeptide Y content in some sympathetically innervated tissues of the guinea-pig.
Franco-Cereceda A; Nagata M; Svensson TH; Lundberg JM
Eur J Pharmacol; 1987 Oct; 142(2):267-73. PubMed ID: 3691641
[TBL] [Abstract][Full Text] [Related]
9. Modulatory interactions of neuropeptide Y (NPY) on sympathetic neurotransmission.
Linton-Dahlöf P
Acta Physiol Scand Suppl; 1989; 586():1-85. PubMed ID: 2557726
[TBL] [Abstract][Full Text] [Related]
10. Co-release of neuropeptide Y and catecholamines upon adrenal activation in the cat.
Lundberg JM; Fried G; Pernow J; Theodorsson-Norheim E
Acta Physiol Scand; 1986 Feb; 126(2):231-8. PubMed ID: 3754683
[TBL] [Abstract][Full Text] [Related]
11. Repeated renal and splenic sympathetic nerve stimulation in anaesthetized pigs: maintained overflow of neuropeptide Y in controls but not after reserpine.
Modin A; Pernow J; Lundberg JM
J Auton Nerv Syst; 1994 Oct; 49(2):123-34. PubMed ID: 7806765
[TBL] [Abstract][Full Text] [Related]
12. Effects of the neuropeptide Y Y2 receptor antagonist BIIE0246 on sympathetic transmitter release in the pig in vivo.
Malmström RE; Lundberg JN; Weitzberg E
Naunyn Schmiedebergs Arch Pharmacol; 2002 Feb; 365(2):106-11. PubMed ID: 11819028
[TBL] [Abstract][Full Text] [Related]
13. Adrenergic and non-adrenergic mechanisms in sympathetic vascular control of the nasal mucosa.
Lacroix JS
Acta Physiol Scand Suppl; 1989; 581():1-63. PubMed ID: 2568728
[TBL] [Abstract][Full Text] [Related]
14. Sympathetic vascular control of the pig nasal mucosa (III): Co-release of noradrenaline and neuropeptide Y.
Lacroix JS; Stjärne P; Anggärd A; Lundberg JM
Acta Physiol Scand; 1989 Jan; 135(1):17-28. PubMed ID: 2911948
[TBL] [Abstract][Full Text] [Related]
15. Neuropeptide Y and reserpine-resistant vasoconstriction evoked by sympathetic nerve stimulation in the dog skeletal muscle.
Pernow J; Kahan T; Lundberg JM
Br J Pharmacol; 1988 Jul; 94(3):952-60. PubMed ID: 3179619
[TBL] [Abstract][Full Text] [Related]
16. Differential effects of reserpine and 6-hydroxydopamine on neuropeptide Y (NPY) and noradrenaline in peripheral neurons.
Lundberg JM; Saria A; Franco-Cereceda A; Hökfelt T; Terenius L; Goldstein M
Naunyn Schmiedebergs Arch Pharmacol; 1985 Jan; 328(3):331-40. PubMed ID: 2858824
[TBL] [Abstract][Full Text] [Related]
17. Effects of antihypertensive drugs on sympathetic vascular control in relation to neuropeptide Y.
Lundberg JM; Pernow J; Franco-Cereceda A; Rudehill A
J Cardiovasc Pharmacol; 1987; 10 Suppl 12():S51-68. PubMed ID: 2455193
[TBL] [Abstract][Full Text] [Related]
18. Possible involvement of neuropeptide Y in sympathetic vascular control of canine skeletal muscle.
Pernow J; Kahan T; Hjemdahl P; Lundberg JM
Acta Physiol Scand; 1988 Jan; 132(1):43-50. PubMed ID: 2906210
[TBL] [Abstract][Full Text] [Related]
19. Non-adrenergic, non-cholinergic vascular control with reference to neuropeptide Y, vasoactive intestinal polypeptide and nitric oxide.
Modin A
Acta Physiol Scand Suppl; 1994; 622():1-74. PubMed ID: 7524267
[TBL] [Abstract][Full Text] [Related]
20. Alterations in circulating levels and cardiovascular tissue content of neuropeptide Y-like immunoreactivity during the development of deoxycorticosterone acetate-salt hypertension in the rat.
Moreau P; de Champlain J; Yamaguchi N
J Hypertens; 1992 Aug; 10(8):773-80. PubMed ID: 1325509
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]